FGF-23 and the progression of coronary arterial calcification in patients new to dialysis.
about
Evolution of Cardiovascular Disease During the Transition to End-Stage Renal Disease.FGF-23 associated with the progression of coronary artery calcification in hemodialysis patients.Association of serum phosphorus variability with coronary artery calcification among hemodialysis patients.Vascular calcification in patients with nondialysis CKD over 3 yearsEffect of High-Flux Dialysis on Circulating FGF-23 Levels in End-Stage Renal Disease Patients: Results from a Randomized Trial.High Parathyroid Hormone Level and Osteoporosis Predict Progression of Coronary Artery Calcification in Patients on Dialysis.Association between Density of Coronary Artery Calcification and Serum Magnesium Levels among Patients with Chronic Kidney Disease.Fibroblast growth factor-23: what we know, what we don't know, and what we need to know.Fibroblast growth factor 23, the ankle-brachial index, and incident peripheral artery disease in the Cardiovascular Health Study.Should monitoring of fibroblast growth factor-23 levels in dialysis patients be a part of routine clinical practice?Paricalcitol- or cinacalcet-centred therapy affects markers of bone mineral disease in patients with secondary hyperparathyroidism receiving haemodialysis: results of the IMPACT-SHPT study.Prognostic value of bone- and vascular-derived molecular biomarkers in hemodialysis and renal transplant patients: a systematic review and meta-analysis.Fibroblast growth factor 23, hepatocyte growth factor, interleukin-6, high-sensitivity C-reactive protein and soluble urokinase plasminogen activator receptor. Inflammation markers in chronic haemodialysis patients?High serum phosphorus and FGF 23 levels are associated with progression of coronary calcifications.Risk factors for progression of coronary artery calcification in patients with chronic kidney disease: The CRIC study.Etelcalcetide, A Novel Calcimimetic, Prevents Vascular Calcification in A Rat Model of Renal Insufficiency with Secondary Hyperparathyroidism.Serum sclerostin level might be a potential biomarker for arterial stiffness in prevalent hemodialysis patients.FGF-23 levels are associated with vascular calcification, but not with atherosclerosis, in hemodialysis patients.The role of fibroblast growth factor-23 in cardiorenal syndrome.Fibroblast growth factor-23 levels are associated with vascular calcifications in peritoneal dialysis patients.Circulating Fibroblast Growth Factor-23 Levels are Associated with an Increased Risk of Anemia Development in Patients with Nondialysis Chronic Kidney Disease.
P2860
Q30234797-9EE7FFB0-136B-4F32-9EC5-EF0A4D9DEE2BQ35030290-84CABE8C-DE64-4499-8CE7-BD513D785082Q35152692-C597B839-1333-4641-B5D2-C8FA29560A52Q35278497-D41E9474-C862-4735-80E6-DB5CB480F5A7Q35646353-F8E26845-C0AE-460F-AFB8-742C861A2DECQ36104814-2A2FCE2E-CC06-4646-998A-BB5893A3C2C7Q36143198-9D2AD35F-4AB7-4AF5-9464-D835313C558BQ37162723-A46BFD4C-B179-4844-9FDD-FB8BBA46C624Q37589683-254CB589-9584-4317-873A-1EBE9A5DD743Q38231420-CC02C109-C6CB-417A-A303-ADBE0A3EF2B2Q38436799-CC646C7D-F624-4D73-9AF4-00C34509CD5DQ39056902-B0873543-4618-43AA-A840-83260F32F697Q43460629-ABB1BCBE-6700-4854-BC66-2ACE7B53E70DQ47843993-B2EEAE84-9B03-413B-9F84-69D8512EB265Q49833748-4E41A794-0133-4E86-A1DD-04F6DC0AF4C3Q50077724-A64213CF-D3E5-4DBF-8717-15B1225E230DQ51679309-C1A99E31-20DF-4EFB-9A64-314BACF09E4AQ52985054-A86B27DA-5E70-480B-84B3-BD4525BCE3FAQ53989980-6B851CC3-78D4-450D-91CA-86AF7A33E1BEQ54700038-D51E63AC-493D-4EF1-A327-447CC94D80ADQ54965740-A99DC698-9B1D-40DC-A094-133EBC4EB3A4
P2860
FGF-23 and the progression of coronary arterial calcification in patients new to dialysis.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
FGF-23 and the progression of ...... n in patients new to dialysis.
@ast
FGF-23 and the progression of ...... n in patients new to dialysis.
@en
type
label
FGF-23 and the progression of ...... n in patients new to dialysis.
@ast
FGF-23 and the progression of ...... n in patients new to dialysis.
@en
prefLabel
FGF-23 and the progression of ...... n in patients new to dialysis.
@ast
FGF-23 and the progression of ...... n in patients new to dialysis.
@en
P2093
P2860
P356
P1476
FGF-23 and the progression of ...... n in patients new to dialysis.
@en
P2093
Abigail May Khan
Harold Litt
Julio A Chirinos
Sylvia E Rosas
P2860
P304
P356
10.2215/CJN.02160212
P577
2012-09-20T00:00:00Z